Literature DB >> 33711786

Mitochondrial apurinic/apyrimidinic endonuclease Apn1 is not critical for the completion of the Plasmodium berghei life cycle.

Pratik Narain Srivastava1, Sunil Kumar Narwal1, Satish Mishra2.   

Abstract

Mitochondrion is an essential organelle in malaria parasite and its DNA must be maintained for optimal function during its complex life cycle. Base excision repair is one of the major pathways by which this is achieved. Apurinic/apyrimidinic (AP) endonucleases are important components of this pathway as they create a nick at the 5'-phosphodiester bond in the AP site and generate free 5'-phosphate and 3'-hydroxyl groups. Two class II AP endonucleases (Apn1 and Ape1) have been annotated in the Plasmodium berghei genome. Using reverse genetic approaches, we provide direct evidence that Apn1 is exclusively localized to the mitochondria of P. berghei. Surprisingly, our gene deletion study revealed a completely dispensable role of Apn1 for the entirety of the P. berghei life cycle. Apn1- parasites were found to successfully grow in the blood. They were transmitted normally to the mosquito midguts and salivary glands. Sporozoites obtained from the salivary glands were infective and achieved similar patency as WT. Our results help emphasize the non-availability of this enzyme as a plausible drug target. We also emphasize the importance of genetic validation of antimalarial drug targets before furthering them down the drug discovery pipeline.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apn1; DNA repair; Mitochondria; Plasmodium; Sporozoites

Year:  2021        PMID: 33711786     DOI: 10.1016/j.dnarep.2021.103078

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  1 in total

1.  Bloom Helicase Along with Recombinase Rad51 Repairs the Mitochondrial Genome of the Malaria Parasite.

Authors:  Payal Jha; Abhilasha Gahlawat; Sunanda Bhattacharyya; Sandeep Dey; Kota Arun Kumar; Mrinal Kanti Bhattacharyya
Journal:  mSphere       Date:  2021-11-03       Impact factor: 4.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.